826
Views
73
CrossRef citations to date
0
Altmetric
Review

Potential of APDM mobility lab for the monitoring of the progression of Parkinson’s disease

&
Pages 455-462 | Received 22 Sep 2015, Accepted 09 Feb 2016, Published online: 03 May 2016

References

  • Bach J-P, Ziegler U, Deuschl G, et al. Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord. 2011;26:2286–2290.
  • Morris ME. Movement disorders in people with Parkinson disease: a model for physical therapy. Phys Ther. 2000;80:578–597.
  • Shoenberg BS. Epidemiology of movement disorders. In: Marsden CD, Fahn S, editor. Movement Disorders. 2nd ed. London (UK): Butterworth; 1987. p. 17–32.
  • Deane KH, Flaherty H, Daley DJ, et al. Priority setting partnership to identify the top 10 research priorities for the management of Parkinson’s disease. BMJ Open. 2014;4:e006434.
  • Mellone S, Palmerini L, Cappello A, et al. Hilbert-Huang-based tremor removal to assess postural properties from accelerometers. IEEE Trans Biomed Eng. 2011;58:1752–1761.
  • Curtze C, Nutt JG, Carlson-Kuhta P, et al. Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord. 2015;30:1361–1370.
  • Horak FB, Mancini M. Objective biomarkers of balance and gait for Parkinson’s disease using body-worn sensors. Mov Disord. 2013;28:1544–1551.
  • Fahn S. Description of Parkinson’s disease as a clinical syndrome. Ann N Y Acad Sci. 2003;991:1–14.
  • Schapira AH. Etiology and pathogenesis of Parkinson disease. Neurol Clin. 2009;27:583–603, v.
  • Frank JS, Horak FB, Nutt J. Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol. 2000;84:2440–2448.
  • Collomb-Clerc A, Welter M-L. Effects of deep brain stimulation on balance and gait in patients with Parkinson’s disease: a systematic neurophysiological review. Neurophysiol Clin. 2015;45:371–388.
  • Fasano A, Aquino CC, Krauss JK, et al. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol. 2015;11:98–110.
  • Burleigh AL, Horak FB, Burchiel KJ, et al. Effects of thalamic stimulation on tremor, balance, and step initiation: a single subject study. Mov Disord. 1993;8:519–524.
  • Rocchi L, Carlson-Kuhta P, Chiari L, et al. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg. 2012;117:1141–1149.
  • St George RJ, Carlson-Kuhta P, Burchiel KJ, et al. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg. 2012;116:1347–1356.
  • St George RJ, Carlson-Kuhta P, King LA, et al. Compensatory stepping in Parkinson’s disease is still a problem after deep brain stimulation randomized to STN or GPi. J Neurophysiol. 2015;114:1417–1423.
  • St George RJ, Carlson-Kuhta P, Nutt JG, et al. The effect of deep brain stimulation randomized by site on balance in Parkinson’s disease. Mov Disord. 2014;29:949–953.
  • St George RJ, Nutt JG, Burchiel KJ, et al. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010;75:1292–1299.
  • Bloem BR, Beckley DJ, Van Hilten BJ, et al. Clinimetrics of postural instability in Parkinson’s disease. J Neurol. 1998;245:669–673.
  • Dibble LE, Lange M. Predicting falls in individuals with Parkinson disease: a reconsideration of clinical balance measures. J Neurol Phys Ther. 2006;30:60–67.
  • Ebersbach G, Baas H, Csoti I, et al. Scales in Parkinson’s disease. J Neurol. 2006;253 (Suppl 4):IV32–5.
  • Haaxma CA, Bloem BR, Borm GF, et al. Comparison of a timed motor test battery to the Unified Parkinson’s disease Rating Scale-III in Parkinson’s disease. Mov Disord. 2008;23:1707–1717.
  • Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing. 1997;26:353–357.
  • Mitchell SL, Harper DW, Lau A, et al. Patterns of outcome measurement in Parkinson’s disease clinical trials. Neuroepidemiology. 2000;19:100–108.
  • Chrischilles EA, Rubenstein LM, Voelker MD, et al. The health burdens of Parkinson’s disease. Mov Disord. 1998;13:406–413.
  • Hagell P, Whalley D, McKenna SP, et al. Health status measurement in Parkinson’s disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord. 2003;18:773–783.
  • Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18:738–750.
  • Stocchi F, Ruggieri S, Brughitta G, et al. Problems in daily motor performances in Parkinson’s disease: the continuous dopaminergic stimulation. J Neural Transm Suppl. 1986;22:209–218.
  • Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Control Clin Trials. 2003;24:182–199.
  • Isacson D, Bingefors K, Kristiansen IS, et al. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion. Acta Neurol Scand. 2008;118:379–386.
  • Hobert MA, Maetzler W, Aminian K, et al. Technical and clinical view on ambulatory assessment in Parkinson’s disease. Acta Neurol Scand. 2014;130:139–147.
  • Lopane G, Mellone S, Chiari L, et al. Dyskinesia detection and monitoring by a single sensor in patients with Parkinson’s disease. Mov Disord. 2015;30:1267–1271.
  • Mariani B, Jimenez MC, Vingerhoets FJ, et al. On-shoe wearable sensors for gait and turning assessment of patients with Parkinson’s disease. IEEE Trans Biomed Eng. 2013;60:155–158.
  • Palmerini L, Mellone S, Avanzolini G, et al. Quantification of motor impairment in Parkinson’s disease using an instrumented timed up and go test. IEEE Trans Neural Syst Rehabil Eng. 2013;21:664–673.
  • Perez Lloret S, Rossi M, Cardinali DP, et al. Actigraphic evaluation of motor fluctuations in patients with Parkinson’s disease. Int J Neurosci. 2010;120:137–143.
  • Weiss A, Herman T, Plotnik M, et al., et al. Can an accelerometer enhance the utility of the timed up & go test when evaluating patients with Parkinson’s disease? Med Eng Phys. 2010;32:119–125.
  • Hulbert S, Ashburn A, Robert L, et al. A narrative review of turning deficits in people with Parkinson’s disease. Disabil Rehabil. 2015;37:1382–1389.
  • Zampieri C, Salarian A, Carlson-Kuhta P, et al. The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2010;81:171–176.
  • Sterling NW, Cusumano JP, Shaham N, et al., et al. Dopaminergic modulation of arm swing during gait among Parkinson’s disease patients. J Parkinsons Dis. 2015;5:141–150.
  • Mancini M, King L, Salarian A, et al. Mobility lab to assess balance and gait with synchronized body-worn sensors. J Bioengineer Biomedical Sci S. 2012;1:2.
  • Spain RI, Mancini M, Horak FB, et al. Body-worn sensors capture variability, but not decline, of gait and balance measures in multiple sclerosis over 18 months. Gait Posture. 2014;39:958–964.
  • Spain RI, St George RJ, Salarian A, et al., et al. Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed. Gait Posture. 2012;35:573–578.
  • Mancini M, Salarian A, Carlson-Kuhta P, et al., et al. ISway: a sensitive, valid and reliable measure of postural control. J Neuroeng Rehabil. 2012;9:59.
  • Salarian A, Horak FB, Zampieri C, et al. iTUG, a sensitive and reliable measure of mobility. IEEE Trans Neural Syst Rehabil Eng. 2010;18:303–310.
  • King LA, Horak FB, Mancini M, et al., et al. Instrumenting the balance error scoring system for use with patients reporting persistent balance problems after mild traumatic brain injury. Arch Phys Med Rehabil. 2014;95:353–359.
  • Mancini M, Horak FB, Zampieri C, et al. Trunk accelerometry reveals postural instability in untreated Parkinson’s disease. Parkinsonism Relat Disord. 2011;17:557–562.
  • Dewey DC, Miocinovic S, Bernstein I, et al., et al. Automated gait and balance parameters diagnose and correlate with severity in Parkinson disease. J Neurol Sci. 2014;345:131–138.
  • Mancini M, Carlson-Kuhta P, Zampieri C, et al. Postural sway as a marker of progression in Parkinson’s disease: a pilot longitudinal study. Gait Posture. 2012;36:471–476.
  • Mancini M, El-Gohary M, Pearson S, et al., et al. Continuous monitoring of turning in Parkinson’s disease: Rehabilitation potential. Neurorehabilitation. 2015;37:3–10.
  • El-Gohary M, Pearson S, McNames J, et al., et al. Continuous monitoring of turning in patients with movement disability. Sensors (Basel). 2013;14:356–369.
  • Del Din S, Godfrey A, Rochester L. Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson’s disease: toward clinical and at home use. IEEE J Biomed Health Inform. 2015 Apr 2. [Epub ahead of print].
  • Weiss A, Herman T, Giladi N, et al. New evidence for gait abnormalities among Parkinson’s disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days. J Neural Transm (Vienna). 2015;122:403–410.
  • Weiss A, Sharifi S, Plotnik M, et al. Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a body-worn accelerometer. Neurorehabil Neural Repair. 2011;25:810–818.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.